Luncheon Seminar 1 - 日本神経学会...－139－ Luncheon Seminar 1 LS-01 May 21（ Wed） 12:00～13:00 Room2（Sunpalace Palace Room 2F） Safety and effectiveness of novel oral

－139－

Luncheon Seminar 1

LS-01 May 21 （Wed）　12:00～13:00　Room2（Sunpalace Palace Room 2F）

Safety and effectiveness of novel oral anticoagulants: evidence from post-marketing surveillance and Fukuoka Stroke Registry

Chair: Koji Abe（ Professor of Department of Neurology and Neuroscience,

Okayama University School of Medicine / Professor of Department of Neurology, Okayama University Graduate School of Medicine, Dentistry, Pharmaceutical Science, Okayama, Japan）

Speaker: Takanari Kitazono（ Professor and Chairman of Department of Medicine and

Clinical Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan）

Sponsored by：Bayer Yakuhin, Ltd.

Luncheon Seminar 2

LS-02 May 21 （Wed）　12:00～13:00　Room3（FICC 201 2F）

Basic and clinical research of MuSK antibody-positive myasthenia gravis: Challenge of young

Chair: Masakatsu Motomura（ Nagasaki Institute of Applied Science）

1 Clinical features of MuSK- antibody- positive myasthenia gravis in Japan

Speaker: Ruka Nakata（ Nagasaki University Hospital, First Department of

Internal Medicine）

2 Both presynaptic and postsynaptic dysfunction by disruption of agrin/Lrp4/MuSK signaling

Speaker: Shuuichi Mori（ Tokyo Metropolitan Institute of Gerontology）

3 Anti - MuSK autoantibodies block binding of collagen Q to MuSK !?

Speaker: Kenji Otsuka（ Division of Neurogenetics, Nagoya University Graduate

School of Medicine）Sponsored by：Cosmic Corporation

Luncheon Seminar

－140－

Luncheon Seminar 3

LS-03 May 21 （Wed）　12:00～13:00　Room5（FICC 203 2F）

Treatment Strategy for Post-Stroke Spasticity Chair: Jun Kimura

（ Professor Emeritus Department of Neurology, University of Iowa Health Care）

1 Regaining active function after stroke using BOTOX Speaker: Ryuji Kaji

（ Department of Neurology, Institute of Health-Bioscience, Tokushima University）

2 Clinical practice of Botulinum Toxin treatment and rehabilitation for post-stroke spasticity

Speaker: Isao Inoue（ Division of Neurology and Neuro-Rehabilitation, Fukuoka

Seisyukai Hospital）Sponsored by：GlaxoSmithKline Japan K.K.

Luncheon Seminar 4

LS-04 May 21 （Wed）　12:00～13:00　Room7（FICC Main Hall 3F）

Useful Medication for Home Care of Dementia Patients Chair: Hidetoshi Endo

（ Department of General Medicine, National Center for Geriatrics and Gerontology）

Speaker: Ken Nagata（ Director of Neurology Research Institute for Brain and

Blood Vessels）Sponsored by：DAIICHI SANKYO CO., LTD.

Luncheon Seminar 5

LS-05 May 21 （Wed）　12:00～13:00　Room8（FICC 409+410 4F）

Towards the establishment of mechanism-based treatment for migraine based on “Cephalalgiology”

Chair: Nobuo Araki（ Department of Neurology, Saitama Medical University）

Luncheon Seminar

－141－

Speaker: Norihiro Suzuki（ Department of Neurology, Keio University School of

Medicine）Sponsored by：Pfizer Japan Inc.

Luncheon Seminar 6


A new era of Parkinsonʼs disease treatment Chair: Kenichi Kashihara

（ Department of Neurology, Okayama Kyokuto Hospital） Speaker: Nobutaka Hattori

（ Department of Neurology, Juntendo University School of Medicine）

Sponsored by：Otsuka Pharmaceutical Co., Ltd.

Luncheon Seminar 7


Epieptology in the management of stroke Chair: Hiroshi Sigetou

（ Neurology, Kyushu University Hospital） Speaker: Takahito Morioka

（ Kyushu Rosai Hospital）Sponsored by：Eisai Co., Ltd./Nobelpharma Co., Ltd.

Luncheon Seminar 8

LS-08 May 22 （Thu）　12:50～13:50　Room2（Sunpalace Palace Room 2F）

Watching seizures, reading EEG, and diagnosing epilepsy Chair: Mitsuru Kawamura

（ Professor, Department of Neurology, Showa University School of Medicine）

Speaker: Kazutaka Jin（ Lecturer, Department of Epileptology, Tohoku University

Graduate School of Medicine）Sponsored by：GlaxoSmithKline K.K.

Luncheon Seminar

－142－

Luncheon Seminar 9

LS-09 May 22 （Thu）　12:50～13:50　Room3（FICC 201 2F）

Headache management based on gender difference Chair: Nobuo Araki

（ Department of Neurology, Saitama Medical University） Speaker: Koichi Hirata

（ Department of Neurology, Dokkyo Medical University）Sponsored by：GlaxoSmithKline K.K.

Luncheon Seminar 10


Behavioral Neurology of Dementia Chair: Akira Tamaoka

（ Department of Neurology University of Tsukuba） Speaker: Etsuro Mori

（ Department of Behavioral Neurology and Cognitive Neuroscience Tohoku University Graduate School of Medicine）

Sponsored by：Eisai Co., Ltd.

Luncheon Seminar 11


Image of PD therapy desired by patients －Expectations to the extended release dopamine agonist agents

Chair: Kazuko Hasegawa（ SAGAMIHARA NATIONAL HOSPITAL）

Speaker: Yoshio Tsuboi（ Department of Neurology Fukuoka University Faculty of

Medicine）Sponsored by：Nippon Boehringer Ingelheim Co., Ltd.

Luncheon Seminar

－143－

Luncheon Seminar 12


Clinical utility of dopamine transporter imaging Chair: Nobutaka Hattori

（ Department of Neurology, Juntendo University School of Medicine）

1 Usefulness of Dopamine Transporter SPECT for Differentiation of Dementia with Lewy bodies from Alzheimerʼs disease

Speaker: Eizo Iseki（ PET/CT Dementia Research Center, Juntendo Tokyo

Koto Geriatric Medical Center, Juntendo University School of Medicine）

2 Clinical utility of dopamine transporter imaging in treatment of Parkinsonʼs disease

Speaker: Miho Murata（ Department of Neurology, National Center Hospital,

National Center of Neurology and Psychiatry）Sponsored by：Nihon Medi-Physics Co., Ltd.Supported by：The Japanese Council of Nuclear Neuroimaging

Luncheon Seminar 13

LS-13 May 22 （Thu）　12:50～13:50　Room7（FICC Main Hall 3F）

Treatment of Parkinsonʼs disease: Is Parkinsonʼs disease curable?

Chair: Mitsutoshi Yamamoto（ Takamatsu Neurology Clinic ）

Speaker: Yoshikuni Mizuno（ Juntendo University）

Sponsored by：GlaxoSmithKline Japan K.K.

Luncheon Seminar

－144－

Luncheon Seminar 14

LS-14 May 22 （Thu）　12:50～13:50　Room8（FICC 409+410 4F）

Update and case studies in ataxia Chair: Hidenao Sasaki

（ Department of Neurology, Hokkaido University Graduate School of Medicine）

Speaker: Kinya Ishikawa（ Department of Neurology and Neurological Science,

Tokyo Medical and Dental University, Graduate School of Medical and Dental Sciences）

Sponsored by：Mitsubishi Tanabe Pharma Corporation

Luncheon Seminar 15


Current topics on stroke prevention - Optimal antiplatelet therapy for Japanese patients

Chair: Kazuo Minematsu（ National Cerebral and Cardiovascular Center）

Speaker: Kazutoshi Nishiyama（ Department of Neurology, Kitasato University School of

Medicine）Sponsored by：Sanofi K.K.

Luncheon Seminar 16


Therapeutic Strategy of MS and MG

1 Treatment challenges in multiple sclerosis. How do we treat a disabling chronic disease?

Chair: Ichiro Nakashima（ Department of Neurology, Tohoku University School of

Medicine） Speaker: Hirofumi Ochi

（ Department of Neurology and Geriatric Medicine, Ehime University Graduate School of Medicine）

Luncheon Seminar

Simultaneous Interpretation English Session or Session with English Interpretation

－145－

2 Early aggressive treatment strategy for myasthenia gravis in Kinki University

Chair: Naoki Kawaguchi（ Douwa-kai Neurological Center, Neurology Chiba Clinic）

Speaker: Hidekazu Suzuki（ Department of Neurology, Kinki University School of

Medecine）Sponsored by：Novartis Pharma K.K.

Luncheon Seminar 17


Advancement in the Endovascular Treatment for Acute Ischemic Stroke ~The Introduction of SolitaireTM FR~

Chair: Kazunori Toyoda（ Department of Stroke Neurology, National Cerebral and

Cardiovascular Center Hospital）

1 The Possibiling and the Expectation of SolitaireTM FR from Actual Clinical Use

Speaker: Yuji Matsumaru（ Department of Neuroendovascular Therapy, Toranomon

Hospital）

2 The Future Prospects for the Endovascular Treatment ~The Mechanical Thrombectomy from The Large Clinical Trial~

Speaker: Mikito Hayakawa（ Department of Stroke Neurology, National Cerebral and

Cardiovascular Center Hospital）Sponsored by：Covidien Japan Co., Ltd.

Luncheon Seminar 18


Quick & Useful Tips in Clinical Practice: “Diagnosis and Treatment for Treatable Rare Diseases”

Chair: Ryosuke Takahashi（ Department of Neurology, Kyoto University Graduate

School of Hospital, Kyoto, Japan）

Luncheon Seminar

－146－

1 Treatable metabolic muscle disease -Neurologists should not miss it

Speaker: Ichizo Nishino（ Department of Neuromuscular Research, National Center

of Neurology and Psychiatry, Tokyo, Japan）

2 Neurological Aspects of Fabry Disease -Benefits of early and high dosed enzyme replacement therapy

Speaker: Max Josef Hilz（ University of Erlangen-Nuremberg, Erlangen, Germany /

New York University, New York, NY, USA）Sponsored by：Genzyme Japan K.K.

Luncheon Seminar 19

LS-19 May 22 （Thu）　12:50～13:50　Room13（FICC 401+402+403 4F）

Mechanisms underlying neuropathic pain: evidence from glial cells

Chair: Masatoyo Nishizawa（ Department of Neurology, Brain Research Institute, Niigata

University） Speaker: Makoto Tsuda

（ Department of Molecular and System Pharmacology Graduate School of Pharmaceutical Sciences, Kyushu University）

Sponsored by：Pfizer Japan Inc. / Eisai Co., Ltd.

Luncheon Seminar 20

LS-20 May 22 （Thu）　12:50～13:50　Room14（FICC 404+405+406 4F）

Spasticity treatment and intrathecal baclofen therapy in neurology

Chair: Hidehiro Mizusawa（ National Center Hospital, NCNP / Department of Neurology

and Neurological Science, Graduate School, Tokyo Medical and Dental University）

Luncheon Seminar

－147－

1 Usefulness of intrathecal baclofen therapy for post-stroke spasticity

Speaker: Kazunori Tanaka（ Department of Neurosurgery, Saiseikai Matsuyama

Hospital）

2 Outlines of hereditary spastic paraplegia and intrathecal baclofen therapy

Speaker: Yoshihisa Takiyama（ Department of Neurology, Interdisciplinary Graduate

School of Medicine and Engineering, University of Yamanashi）

Sponsored by：Daiichi Sankyo Co., Ltd.

Luncheon Seminar 21

LS-21 May 23 （Fri）　12:15～13:15　Room2（Sunpalace Palace Room 2F）

Discover iNPH: The review of pathophysiology & epidemiological topics in iNPH

Chair: Yasuo Terayama（ Department of Neurology and Gerontology, Iwate Medical

University School of Medicine） Speaker: Nagato Kuriyama

（ Department of Epidemiology for Community health and Medicine, Kyoto Prefectural University of Medicine）

Sponsored by：Codman & CMF Johnson & Johnson K.K.

Luncheon Seminar 22

LS-22 May 23 （Fri）　12:15～13:15　Room3（FICC 201 2F）

Clinical advantage of Rivastigmine, especially for executive function

Chair: Hideo Hara（ Department of Internal Medicine, Saga University Faculty

of Medicine） Speaker: Ayumi Okumura

（ Okumura Medical Center and Gifu Neuroscience Society）Sponsored by：ONO PHARMACEUTICAL CO., LTD.

Luncheon Seminar

－148－

Luncheon Seminar 23


What can we do for headache patients? Techniques for diagnosis and treatment to enhance patientsʼ satisfaction

Chair: Fumihiko Sakai（ Saitama Neuropsychiatric Institute）

Speaker: Hisaka Igarashi（ Headache care Unit, Fujitsu Clinic）

Sponsored by：Eisai Co., Ltd.

Luncheon Seminar 24


Treatment for Parkinsonʼs disease -from early stage to advanced stage-

Chair: Yoshikazu Ugawa（ Department of Neurology, Fukushima Medical University

School of Medicine） Speaker: Fusako Yokochi

（ Department of Neurology, Tokyo Metropolitan Neurological Hospital）

Sponsored by：GlaxoSmithKline Japan K.K.

Luncheon Seminar 25


Principal & Case Presentation in Drug Treatment of Epilepsy

Chair: Sadatoshi Tsuji（ School of Health and Sciences at Fukuoka, International

University of Health and Welfare） Speaker: Akio Ikeda

（ Department of Epilepsy, Movement Disorders and Physiology, Kyoto University Graduate School of Medicine）

Sponsored by：UCB Japan Co., Ltd./Otsuka Pharmaceutical Co., Ltd.

Luncheon Seminar

－149－

Luncheon Seminar 26

LS-26 May 23 （Fri）　12:15～13:15　Room7（FICC Main Hall 3F）

Stroke Prevention in AF : Efficacy and Safety of Dabigatran

Chair: Masahiro Yasaka（ Department of Cerebrovascular Medicine and Neurology,

Clinical Research Institute, National Hospital Organization Kyushu Medical Center）

Speaker: Kazumi Kimura（ Stroke Center / Department of Stroke Medicine

Kawasaki Medical School）Sponsored by：Nippon Boehringer Ingelheim Co., Ltd.

Luncheon Seminar 27

LS-27 May 23 （Fri）　12:15～13:15　Room8（FICC 409+410 4F）

Reconsidering treatment strategies for multiple sclerosis Chair: Jun-ichi Kira

（ Department of Neurology, Neurological Institute, Graduate school of Medical Sciences, Kyushu University, Fukuoka, Japan）

Speaker: Jin Nakahara（ Department of Neurology, Keio University School of

Medicine）Sponsored by：Bayer Yakuhin, Ltd.

Luncheon Seminar 28


Fabry disease: a treatable rare disease neurologists may encounter

Chair: Yoshiki Sekijima（ Department of Medicine （Neurology and Rheumatology）,

Shinshu University School of Medicine）

Luncheon Seminar

－150－

1 Fabry Disease ~Early diagnosis and treatment are the most important~

Speaker: Yoshikatsu Eto（ Advanced Clinical Research Center & Institute for the

Treatment of Genetic Diseases, Institute of Neurological Disorders/ Professor emeritus, The Jikei University School of Medicine）

2 Neurological manifestations in Fabry disease Speaker: Setsu Sawai

（ Division of Clinical Genetics, Chiba University Hospital/Department of Neurology, Graduate School of Medicine, Chiba University）

Sponsored by：Dainippon Sumitomo Pharma Co., Ltd

Luncheon Seminar 29


Stroke treatment -The present condition and foresight- Chair: Kazutoshi Nishiyama

（ Department of Neurology Kitasato University, School of Medicine）

1 Integrated vascular strategy to combat cerebrovascular diseases

Speaker: Masafumi Ihara（ National Cerebral and Cardiovascular Center, Division of

Neurology, Department of Stroke and Cerebrovascular Diseases）

2 Cerebral vessel disease and blood inf lammatory biomarker

Speaker: Kazuo Kitagawa（ Department of Neurology, Tokyo Womenʼs Medical

University）Sponsored by：Otsuka Pharmaceutical Co., Ltd.

Luncheon Seminar


－151－

Luncheon Seminar 30


Gene Therapy for Neurodegenerative Disorders of the Brain; will it ever work?

Chair: Yoshio Tsuboi（ Department of Neurology, Fukuoka University School of

Medicine） Speaker: Krystof Bankiewicz

（ Department of Neurological Surgery, University of California, San Francisco）

Sponsored by：FP Pharmaceutical Corporation

Luncheon Seminar 31

LS-31 May 23 （Fri）　12:15～13:15　Room13（FICC 401+402+403 4F）

Clinical diversity of CIDP and prospective of the therapies Chair: Gen Sobue

（ Department of Neurology, Nagoya University Graduate School of Medicine）

Speaker: Masahiro Iijima（ Department of therapeutics for intractable neurological

disorders （Department of Neurology, Nagoya University））Sponsored by：NIHON PHARMACEUTICAL CO, LTD.

Luncheon Seminar 32

LS-32 May 23 （Fri）　12:15～13:15　Room14（FICC 404+405+406 4F）

Elucidation of ALS pathology and the current clinical practice of ALS

Chair: Masashi Aoki（ Professor and Chair in Department of Neurology, Tohoku

University School of Medicine）

1 Why ALS predominantly affects the motor system? - Lesson from frontier of molecular mechanism of ALS-

Speaker: Osamu Onodera（ Professor in Resource Branch for Brain Disease, Brain

Research Institute, Niigata University）

Luncheon Seminar

－152－

2 What we can do now for patients affected by ALS Speaker: Michio Nonaka

（ Chief in Motor Neuron Disease Division, Hokuyukai Neurological Hospital）

Sponsored by：Sanofi K.K.

Luncheon Seminar 33

LS-33 May 24 （Sat）　12:15～13:15　Room2（Sunpalace Palace Room 2F）

Treatment of Parkinsonʼs Disease : To Maximize Drug Efficacy

Chair: Takayuki Taniwaki（ Division of Respirology, Neurology and Rheumatology,

Department of Medicine, Kurume University of Medicine） Speaker: Miho Murata

（ National Center Hospital, Department of Neurology/ National Center Hospital, National Center of Neurology & Psychiatry）

Sponsored by：Dainippon Sumitomo Pharma Co., Ltd

Luncheon Seminar 34

LS-34 May 24 （Sat）　12:15～13:15　Room3（FICC 201 2F）

Update of pathophysiology and treatment of neuropathic pain

Chair: Hitoshi Yasuda（ Clinic of the Foundation Shiga Health Research Center）

Speaker: Masayuki Baba（ Aomori Prefectural Central Hospital）

Sponsored by：SHIONOGI & CO., LTD./Eli Lilly Japan K.K.

Luncheon Seminar 35


Clinical Subtypes of Alzheimerʼs Disease Chair: Shun Shimohama

（ Department of Neurology, Sapporo Medical University School of Medicine）

Luncheon Seminar

－153－

Speaker: Yumiko Motoi（ Graduate School of Juntendo University, Department

of Diagnosis, Prevention and Treatment of Dementia, Department of Neurology）

Sponsored by：Janssen Pharmaceutical K. K.

Luncheon Seminar 36


Novel perspective of DBS: Proper indication ~Reviewing actual cases~

Chair: Atsushi Takeda（ National Hospital Organization: Sendai-Nishitaga Hospital）

Speaker: Hidemoto Saiki（ Department of Neurology, Kitano Hospital, The Tazuke

Kofukai Medical Research Instisute） Yasushi Shimo

（ Department of Research and Therapeutics for Movement Disorders, Department of Neurology, Juntendo University School of Medicine）

Yasuhiko Baba（ Department of Neurology, Tokai University School of

Medicine）Sponsored by：Medtronic Japan Co., Ltd.

Luncheon Seminar 37

LS-37 May 24 （Sat）　12:15～13:15　Room7（FICC Main Hall 3F）

Outcomes of efforts for the better PD treatment with higher patientʼs satisfaction in the past 5 years -What two nation-wide PD patientsʼ surveys in 2008 and 2013 suggested-

Chair: Nobutaka Hattori（ Department of Neurology, Juntendo University Graduate

School of Medicine） Speaker: Kenichi Fujimoto

（ Jichiidai Station Brain Clinic）Sponsored by：Novartis Pharma K.K.

Luncheon Seminar

－154－

Luncheon Seminar 38


Therapeutic strategy for the treatment of Restless Legs Syndrome

Chair: Naohisa Uchimura（ Department of Neuropsychiatry, Kurume University,

School of Medicine） Speaker: Koichi Hirata

（ Department of Neurology, Dokkyo Medical University）Sponsored by：Astellas Pharma Inc.

Luncheon Seminar 39

LS-39 May 24 （Sat）　12:15～13:15　Room12（FICC 502+503 5F）

Letʼs learn MG from Prof. Burns! Chair: Kimiaki Utsugisawa

（ Hanamaki General Hospital, Department of Neurology）

1 Impacts from Dr Burns on Japanese MG specialists Speaker: Yuriko Nagane

（ Hanamaki General Hospital, Department of Neurology）

2 Quality of Life in Myasthenia Gravis Speaker: Ted M Burns

（ University of Virginia, Department of Neurology）Sponsored by：Japan Blood Products Organization

Luncheon Seminar 40

LS-40 May 24 （Sat）　12:15～13:15　Room14（FICC 404+405+406 4F）

The beginning of a new age of the treatment of the protein misfolding disease ~Diagnosis and Novel therapy of TTR-FAP~

Chair: Hidehiro Mizusawa（ National Center Hospital, National Center of Neurology and

Psychiatry / Department of Neurology and Neurological Science, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University）

Luncheon Seminar


－155－

Speaker: Yoshiki Sekijima（ Department of Medicine, Neurology and Rheumatology,

Shinshu Univ. School of Medicine）Sponsored by：Pfizer Japan Inc.

Evening Seminar 1

ES-01 May 21 （Wed）　18:10～19:35　Room3（FICC 201 2F）

ASK the Experts: The Secret of Fingolimod Usage

1 Future perspective of fingolimod usage in Japanese patients with MS, based on the results of Japanese fingolimod core and extension studies and the post-marketing surveillance

Speaker: Ichiro Nakashima（ Tohoku University）

2 Round Table Discussion Fingolimod: An application to your MS patients

Chair: Hirofumi Ochi（ Ehime University）

Speaker: Masaaki Niino（ Hokkaido Medical Center）

Ichiro Nakashima（ Tohoku University）

Takuya Matsushita（ Kyushu University）

Sponsored by：Mitsubishi Tanabe Pharma Corporation

Evening Seminar 2


Diagnosis and therapy of Parkinsonʼs disease -Crosstalk of clinical research and clinical practice-

Chair: Tetsuya Maeda（ Research Institute for Brain and Blood Vessels）

1 How to treat Parkinsonʼs disease: A guide based on answers to clinical questions

Speaker: Ryosuke Takahashi（ Department of Neurology, Kyoto University）

Luncheon Seminar

Evening Seminar

－156－

2 Controversy: Dyskinesia is not a trouble maker Yes/ No

Speaker: Hirohisa Watanabe（ Department of Neurology, Brain and Mind Research

Center of Nagoya University） Reika Wate

（ Department of Neurology, Kansai Medical University）

3 Clinical practice: What would you do in this case? Speaker: Manabu Doyu

（ Department of Neurology, Aichi Medical University） Hidemoto Saiki

（ Department of Neurology, Kitano hospital）Sponsored by：GlaxoSmithKline Japan K.K.

Evening Seminar 3


The Current Treatment Strategy for Epilepsy ~ Prologue to an New Era ~

Opening Remarks: Sadatoshi Tsuji

（ Dean, School of Health Sciences at Fukuoka / Chairman and Professor, Department of Medical Technology and Sciences, International University of Health and Welfare）

1 Part 1: Antiepileptic Drugs - Mechanism Action Studied by TMS

Chair: Hidehiro Mizusawa（ Director of National Center Hospital, National Center of

Neurology and Psychiatry） Speaker: Yoshikazu Ugawa

（ Professor and Chairman, Department of Neurology, Fukushima Medical University School of Medicine）

2 Part 2: Effectiveness and Role of Lamotrigine in the Paradigm Shift towards New Antiepileptic Drugs: a Therapeutic Strategy Proposed after an Investigation of a Large Number of Cases at a Single Hospital

Chair: Sadatoshi Tsuji（ Dean, School of Health Sciences at Fukuoka / Chairman

and Professor, Department of Medical Technology and Sciences, International University of Health and Welfare）

Evening Seminar


－157－

Speaker: Takamichi Yamamoto（ Director, Comprehensive Epilepsy Center, Seirei

Hamamatsu General Hospital） Closing Remarks: Hidehiro Mizusawa

（ Director of National Center Hospital, National Center of Neurology and Psychiatry）

Sponsored by：GlaxoSmithKline K.K.

Evening Seminar 4

ES-04 May 22 （Thu）　17:50～19:20　Room2（Sunpalace Palace Room 2F）

Natalizumab - New treatment strategy for multiple Sclerosis -

Chair: Takashi Yamamura（ Department of Immunology, National Institute of

Neuroscience, NCNP ）

Keynote Lecture: Discovery and History of Natalizumab Speaker: Takashi Yamamura

（ Department of Immunology, National Institute of Neuroscience, NCNP）

1 A Review on clinical trial data of Natalizumab Speaker: Masaaki Niino

（ Department of Clinical Research, Hokkaido Medical Center）

2 Natalizumab in real clinical practice Speaker: Bernd C. Kieseier

（ Department of Neurology, Heinrich-Heine University, Düsseldorf, Germany）

Sponsored by：Biogen Idec Japan Ltd.

Evening Seminar 5

ES-05 May 22 （Thu）　17:50～19:20　Room3（FICC 201 2F）

Symptomatology and Imaging of Dementia: Case Conferences with Audiences

Chair: Masahito Yamada（ Department of Neurology & Neurobiology of Aging

Kanazawa University Graduate School of Medical Sciences）

Evening Seminar

－158－

Speaker: Toshiya Fukui（ Kawasaki Memorial Hospital）

Seigo Nakano（ Center for Treatment, Care and Research of Dementia,

Medical Co.LTA） Kiyotaka Nemoto

（ Department of Psychiatry, Division of Clinical Medicine, Faculty of Medicine, University of Tsukuba）

Sponsored by：The Japanese Council of Nuclear Neuroimaging /FUJIFILM RI Pharma Co., Ltd.

Evening Seminar 6


Myasthenia gravis Forum, Progress of diagnosis and treatment in myasthenia gravis

Opening Remarks: Takahiko Saida

（ Kyoto Min-Iren Central Hospital）

SessionⅠ Chair: Naoki Kawaguchi

（ Neurology Chiba Clinic, Douwa-kai Neurological Center）

Post Marketing Surveillance of Prograf for patients with myasthenia gravis

Speaker: Hiroaki Yoshikawa（ Kanazawa University）

SessionⅡ Chair: Masakatsu Motomura

（ Nagasaki Institute of Applied Science） Kimiaki Utsugisawa

（ Hanamaki General Hospital）

1 Practical use of new clinical guideline for myasthenia gravis

Speaker: Emiko Tsuda（ Sapporo Medical University School of Medicine）

2 Autoantibodies in MG: recent topics Speaker: Shigeaki Suzuki

（ Keio University School of Medicine）

Evening Seminar

－159－

3 New therapeutic strategies against myasthenia gravis

Speaker: Yuriko Nagane（ Hanamaki General Hospital）

Closing Remarks: Masaharu Takamori

（ Kanazawa-nishi Hospital）Sponsored by：Astellas Pharma Inc.

Evening Seminar 7


Significance of lipid rafts in neurological disorders Chair: Tadashi Miyatake

（ Medical Center for Intractable Neurological Disease Kamagaya General Hospital/ Laboratory for Proteolytic Neuroscience, RIKEN Brain Science Institute）

Speaker: Tatsuro Mutoh（ Department of Neurology, Fujita Health University

School of Medicine）Sponsored by：Nippon Zoki Pharmaceutical Co., Ltd.

Evening Seminar 8

ES-08 May 23 （Fri）　17:20～18:50　Room3（FICC 201 2F）

Advancing Intravascular Treatment for Acute Ischemic Stroke.

Chair: Yasushi Okada（ Clinical Research Institute, National Hospital Organization,

Kyusyu Medical Center）

1 The Present Status for intravenous thrombolysis in ischemic stroke

Speaker: Kazunori Toyoda（ Department of Stroke and Cardiovascular Diseases,

National Cerebral and Cardiovascular Center）

Evening Seminar

－160－

2 The present status of endovascular recanalization -Encouragement for neurologist as an interventionist-

Speaker: Yuji Matsumaru（ Department of Endovascular Neurosurgery, Federation

of National Public Service Personnel Mutual Aid Associations, Toranomon Hospital）

Sponsored by：Stryker Japan K.K.

Evening Seminar 9


The Potential of Alzheimerʼs Disease Treatment Chair: Masahito Yamada

（ Department of Neurology and Neurobiology of Aging, Kanazawa University Graduate School of Medical Science）

1 Deciphering anti-dementia agents in view of the mechanisms of action - A clinical significance of BuChE inhibition by Rivastigmine -

Speaker: Makio Takahashi（ Department of Neurology, Osaka Red Cross Hospital）

2 Drug therapy for Alzheimerʼs disease -Status Quo and Future Considerations

Speaker: Shun Shimohama（ Department of Neurology, Sapporo Medical University

School of Medicine）Sponsored by：Novartis Pharma K.K.

Evening Seminar 10


Reconfirm ! Antithrombotic Therapy Chair: Kortaro Tanaka

（ Department of Neurology, Toyama University Hospital） Speaker: Yasuo Terayama

（ Division of Neurology and Gerontology, Department of Internal Medicine, School of Medicine, Iwate Medical University）

Sponsored by：Bristol-Myers K.K. / Pfizer Japan Inc.

Evening Seminar

－161－

Evening Seminar 11

ES-11 May 23 （Fri）　17:20～18:50　Room7（FICC Main Hall 3F）

A new concept on anti-parkinsonian therapy in Parkinsonʼs disease Approach to the basal ganglia by medicine ~Expectations for neuroprotection~

Chair: Hideki Mochizuki（ Osaka University Graduate School of Medicine,

Department of Neurology） Speaker: Takafumi Hasegawa

（ Tohoku University Graduate School of Medicine, Department of Neuroscience and Sensory Organs, Division of Neurology）

Hideto Miwa（ Juntendo University Nerima Hospital, Department of

Neurology） Kazushi Takahashi

（ Saitama Medical University, Department of Neurology）Sponsored by：Kyowa Hakko Kirin Co., Ltd.

DBS Hands-on Seminar

May 21 （Wed）　12:00～13:00　Room15（FKC Arena 1F）

Programming and Management of Deep Brain Stimulation Chair: Genjiro Hirose

（ Department of Neurology, Brain & Nerve Center, Asanogawa General Hospital）

Speaker: Katsuo Kimura（ Department of Neurology, Yokohama City University

Medical Center）Sponsored by：Medtronic Japan Co., Ltd.

Evening Seminar

DBS Hands-on Seminar

Luncheon Seminar 1 - 日本神経学会...－139－ Luncheon Seminar 1 LS-01 May 21（ Wed） 12:00～13:00 Room2（Sunpalace Palace Room 2F） Safety and effectiveness of novel oral

Documents